MedTrace Logo

Melatonin Adolescent Research Study

NCT04588233 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-01-30

No results posted yet for this study

Summary

The present study will use a within-person, randomized cross-over experimental design to test the effects of exogenous melatonin supplementation on the sleep and daytime functioning of typically developing adolescents with short or disrupted sleep of behavioral origins (i.e., difficulty falling asleep, staying asleep, or premature waking resulting in short or disrupted sleep not attributed to an organic sleep condition).

Conditions

  • Sleep Disorders in Children

Interventions

DIETARY_SUPPLEMENT

Melatonin

Each subject will receive 3mg of melatonin 1 hour prior to bedtime for 12 consecutive nights

OTHER

Placebo

Each subject will receive a placebo 1 hour prior to bedtime for 12 consecutive nights

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Tori Van Dyk, PhD · Loma Linda University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04588233 on ClinicalTrials.gov